Optimal EFAs-BC
Natural health product licensed in Canada
- Licence holder
- Biotics Research Corporation
- NPN or DIN-HM
- 80122050
- Status
- Active licence
- Licence date
- 21 November 2022
- Revision date
- Not provided
- Form
- Capsule, molle
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
- Conditions légales
Linum usitatissimum L.: L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Huile de poisson Source : Engraulidae - en entier Potency : 77 mg Docosahexaenoic acid | Not specified | Not calculated |
| Huile de poisson Source : Engraulidae - en entier Potency : 102.8 mg Eicosapentaenoic acid | 257 mg | Not calculated |
| Linum usitatissimum Source : Graine Potency : 100 mg Oleic acid | Not specified | Not calculated |
| Linum usitatissimum Source : Graine Potency : 205 mg alpha-Linolenic acid | 380 mg | Not calculated |
| Ribes nigrum Source : Graine Potency : 60 mg alpha-Linolenic acid | Not specified | Not calculated |
| Ribes nigrum Source : Graine Potency : 75 mg gamma-Linolenic acid | 500 mg | Not calculated |
Non-medicinal ingredients
Glycérine, Mélange de concentré de tocophérols, Gélatine, Eau
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2 Capsule | 2 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps support cognitive health and/or brain function. Helps support/maintain (normal) heart/cardiovascular health/function. Helps support/maintain eye health/function. Helps support/maintain normal brain function. Helps support/maintain visual health/function. Source of alpha-linolenic acid (ALA) for the maintenance of good health. Source of an essential fatty acid for the maintenance of good health. Source of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) for the maintenance of good health. Source of gamma-linoleic acid (GLA). Source of oleic acid (OA). Source of omega-3 fatty acids for the maintenance of good health. Source of omega-6 fatty acid for the maintenance of good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80122050
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.